The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMW 2019 | Advances in myeloma genomics and tailored patient therapy
Wee Joo Chng
• 14 Sep 2019
Wee Joo Chng, PhD, of the Yong Loo Lin School of Medicine, National University of Singapore, Singapore provides a brief update on multiple myeloma genomics, as has been presented at the International Myeloma Workshop (IMW) 2019, in Boston, MA. He touches on the compelling research into how the gut microbiome may drive disease progression, and how this would affect immunotherapy.
